(Q46041320)
Statements
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children (English)
Birgit Geoerger
Elodie Civade
Isabelle Hennebelle
Jean-Pierre Delord